What are the treatment options for palmar psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Palmar Psoriasis

For palmar psoriasis, a stepwise approach starting with topical therapies and progressing to systemic treatments is recommended, with oral retinoids being particularly effective for palmoplantar disease.

First-Line Topical Therapies

  • High-potency topical corticosteroids are the initial treatment of choice for palmar psoriasis, particularly when used under occlusion to enhance penetration 1
  • Combination therapy with vitamin D analogues (calcipotriene) and topical corticosteroids provides enhanced efficacy and is recommended as first-line treatment 2, 3
  • Fixed combination products containing calcipotriol and corticosteroids are particularly effective and convenient for palmar lesions 2
  • Topical tazarotene 0.1% cream can be used for palmar psoriasis, showing significant improvement when applied under occlusion 4, 2

Second-Line Topical and Phototherapy Options

  • Topical calcineurin inhibitors (tacrolimus and pimecrolimus) are recommended for areas prone to steroid-induced atrophy 5, 6
  • Targeted phototherapy with 308-nm excimer laser is effective for localized palmar psoriasis 1
  • Soak PUVA therapy, where patients soak their palms in methoxsalen solution for 15-30 minutes before UVA exposure, is particularly effective for palmoplantar psoriasis 1
  • Topical PUVA requires treatments 2-3 times weekly for several months for adequate clearing and maintenance 1

Systemic Therapies for Moderate-to-Severe Disease

  • Oral retinoids, particularly acitretin, are highly effective for palmar psoriasis and often considered first-line systemic therapy due to their efficacy in this specific location 1, 7
  • Methotrexate is effective in a significant proportion of patients with palmoplantar psoriasis and is FDA-approved for severe, recalcitrant, disabling psoriasis 1, 8
  • Cyclosporine is effective for palmoplantar psoriasis but should be used with caution due to potential nephrotoxicity 1
  • Biologic agents, including TNF inhibitors (adalimumab), IL-17 inhibitors, and IL-23 inhibitors, should be considered for severe or treatment-resistant cases 1, 9

Treatment Algorithm for Palmar Psoriasis

  1. Initial therapy: High-potency topical corticosteroids combined with vitamin D analogues for 4-8 weeks 2, 3
  2. If inadequate response: Add tazarotene or switch to fixed combination product; consider occlusion to enhance penetration 4, 2
  3. For persistent cases: Consider soak PUVA or targeted phototherapy 1
  4. For moderate-to-severe or recalcitrant disease: Initiate systemic therapy with acitretin (if no contraindications like pregnancy) 1
  5. If acitretin fails or is contraindicated: Consider methotrexate or cyclosporine 1
  6. For severe or treatment-resistant cases: Consider biologic agents, particularly TNF inhibitors, IL-17 inhibitors, or IL-23 inhibitors 1, 9

Important Clinical Considerations

  • Although palmar psoriasis affects a small percentage of body surface area, it is frequently debilitating, painful, and significantly impacts quality of life, justifying the use of systemic therapies 1
  • Caution is needed when using acitretin in women of childbearing potential due to its teratogenic effects and 3-year post-dosing pregnancy restriction 1
  • Methotrexate requires monitoring for hepatotoxicity and bone marrow toxicity, while cyclosporine requires monitoring for nephrotoxicity 1
  • Combination therapy with acitretin and PUVA can enhance efficacy and reduce the number of PUVA treatments needed, potentially decreasing the risk of PUVA-associated skin malignancies 1
  • Paradoxically, TNF-alpha antagonists have rarely been reported to induce palmoplantar pustular psoriasis in patients being treated for other conditions 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Outpatient Treatment Options for Pustular Psoriasis on the Finger

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2007

Guideline

Treatment Options for Nail Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Nail Fold Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical Therapies in Psoriasis.

Indian dermatology online journal, 2017

Research

Adalimumab in the management of palmoplantar psoriasis.

Journal of drugs in dermatology : JDD, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.